Open AccessUse of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
Author(s) -
Calvert Nicholas,
Wood David
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.838
Subject(s) - chondroblastoma , denosumab , medicine , giant cell tumor of bone , pathology , giant cell , radiology , osteoporosis
Key Clinical Message Chondroblastoma is a rare, benign bone tumor that represents 1–2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab.